Med. praxi. 2020;17(3):144-149 | DOI: 10.36290/med.2020.028

New guidelines for the management of dyslipidaemias

prof. MUDr. Eliška Sovová, Ph.D., MBA, MUDr. Markéta Sovová
Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace, LF UP a FN Olomouc

The article provides a summarized overview of the new guidelines for the diagnosis and management of dyslipidaemias that were published in 2019 as a joint effort of the European Society of Cardiology and the European Atherosclerosis Society, and were commented on in a statement of the Czech Society for Atherosclerosis. The new guidelines lower the target LDL cholesterol levels in all risk categories, introduce new SCORE charts for risk assessment, and emphasize the use of calcium score, ultrasound scan of carotid or femoral arteries, and modifying factors (social deprivation, psychiatric comorbidities, left ventricular hypertrophy, atrial fibrillation…) in those with a moderate risk. In younger people, the use of a relative risk chart or estimation of vascular age are recommended.

Keywords: dyslipidaemia, treatment, 2019 guidelines.

Published: June 18, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sovová E, Sovová M. New guidelines for the management of dyslipidaemias. Med. praxi. 2020;17(3):144-149. doi: 10.36290/med.2020.028.
Download citation

References

  1. Mach F, Baigent C, Catapano A, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular riskEuropean Heart Journal, ehz455, https://doi.org/10.1093/eurheartj/ehz455. Published: 31 August 2019. Go to original source...
  2. Vrablík M, Piťha V, Bláha V, et al. Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019. Athero Rev 2019; 4: 19-30. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.